ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FL
March 29, 2017Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today that both companies have entered into a global license agreement for SEL24, a dual PIM/FLT3 inhibitor currently in Phase I/II trials in acute myeloid leuk
Pharma Sources Insight January 2025
